Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Helge, Waal"'
Autor:
Sahar Eshrati, MohammadBagher Saberizafarghandi, Meroe Vameghi, Reza Arezoomandan, Hadi Ranjbar, Thomas Clausen, Helge Waal
Publikováno v:
Harm Reduction Journal, Vol 20, Iss 1, Pp 1-10 (2023)
Abstract Background Despite law enforcement and health interventions, open drug scenes have led to problems in many countries. The problems are, however, insufficiently explored. There are different types of drug scenes in Iran. This study aimed to e
Externí odkaz:
https://doaj.org/article/ac66b082869c444d83caef7c0c06cd33
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Mortality rates and causes of death among individuals in opioid agonist treatment (OAT) vary according to several factors such as geographical region, age, gender, subpopulations, drug culture and OAT status. Patients in OAT are a
Externí odkaz:
https://doaj.org/article/6030aaacad184bb8959e81ff0f840986
Autor:
Meroe Vameghi, Vahid Rashedi, Thomas Clausen, Sahar Eshrati, Mohammad Bagher Saberi Zafarghandi, Reza Arezoomandan, Helge Waal
Publikováno v:
European Addiction Research. 28:87-102
Introduction: Places where people deal and/or use drugs publicly are known as open drug scenes (ODSs). Drug-related community impacts (DRCIs) refer to drug-related issues that negatively influence public and individual health, communities, businesses
Autor:
Helge Waal
Publikováno v:
Tidsskrift for velferdsforskning, Vol 20, Pp 254-256 (2017)
Externí odkaz:
https://doaj.org/article/9015895c761749cbb13c50ce826fe4d1
Autor:
Helge Waal
Publikováno v:
Tidsskrift for Den norske legeforening.
Autor:
Helge, Waal
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 142(1)
Autor:
Ivar Skeie, Thomas Clausen, Arne Jan Hjemsæter, Anne Signe Landheim, Bent Monsbakken, Magne Thoresen, Helge Waal
Publikováno v:
European Addiction Research
Background: Mortality is increased among people with opioid use disorder but reduced while on opioid agonist treatment (OAT). However, the impact of patient and treatment characteristics on mortality and causes of death is insufficiently studied. Obj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d0022d52c8255d6a43dd1daa646f675
http://hdl.handle.net/10852/97378
http://hdl.handle.net/10852/97378
Autor:
Helge Waal
Publikováno v:
Tidsskrift for Den norske legeforening.
Publikováno v:
Substance Abuse: Research and Treatment, Vol 2012, Iss 6, Pp 95-106 (2012)
Externí odkaz:
https://doaj.org/article/e4df2226f7f44dee9bccefc7854e5916
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Health Services Research
BMC Health Services Research
BACKGROUND: Mortality rates and causes of death among individuals in opioid agonist treatment (OAT) vary according to several factors such as geographical region, age, gender, subpopulations, drug culture and OAT status. Patients in OAT are ageing du